by Sam Eskandari | Nov 20, 2018 | News
November 20, 2018, Vancouver, BC – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the appointment of Blair Lowther and Nick Standish as Directors of the Company. Lui Franciosi commented: “We are very...
by Sam Eskandari | Nov 14, 2018 | News
VANCOUVER, British Columbia, Nov. 14, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into a binding share purchase agreement (the “Agreement”) to sell 100% of the...
by Sam Eskandari | Nov 8, 2018 | News
November 8, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that, despite the catastrophic events in Puerto Rico related to Hurricane Maria in the fall of 2017, and the...
by Sam Eskandari | Nov 6, 2018 | News
November 6, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the Closing of the Private Placement announced September 20, 2018. The Company was able to raise $1.56 million...
by Sam Eskandari | Oct 23, 2018 | News
VANCOUVER, British Columbia, Oct. 23, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce a $1.25 million investment to acquire a 25% interest in a 10,000 square foot cannabis growing facility...
by Sam Eskandari | Oct 11, 2018 | News
October 11, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that its CEO Dr. Lui Franciosi and Medical Director Dr. Scott Alexander will be attending the 3rd International...
